Saktimayee M. Roy

A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model

Lenka Munoz, Hantamalala Ralay Ranaivo, Saktimayee M. Roy et al. · Journal of Neuroinflammation · 2007 · 226 citations · Full text

Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology

Nicole Maphis, Shanya Jiang, Guixiang Xu et al. · Alzheimer s Research & Therapy · 2016 · 130 citations · Full text

Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models

Saktimayee M. Roy, Valerie Grum‐Tokars, James P. Schavocky et al. · ACS Chemical Neuroscience · 2015 · 93 citations · Full text

Disease Progression, Synaptic Transmission, Stress Kinases +28

Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction

D. Martin Watterson, Valerie Grum‐Tokars, Saktimayee M. Roy et al. · PLoS ONE · 2013 · 73 citations · Full text

Vivo Chemical Probes, Synaptic Transmission, Neurotransmitter +29

Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits

Wenhui Hu, Hantamalala Ralay Ranaivo, Saktimayee M. Roy et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 62 citations · Full text

Synaptic Plasticity, Novel Therapeutic Suppressor, Neurophysiology +12